ClinicalTrials.gov
public full text
Public Domain
Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis
The primary study objective is to evaluate medium- and long-term safety of HBM9161 in combination with background treatment for gMG patients through the observation on adverse events and laboratory abnormalities during study period.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis#806946
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis#1088256
- Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia Gravis#120141
- Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)#898509
- A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors#1150096
Record · ID 879288
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive